Patent · US Active

Factor VIII formulation

US10238718B2 · kind B2 · utility

0Cited by

6References

24Claims

0Family size

Assignee

CSL LIMITED · AU

Inventors

Uwe Liebing · Dömitz, DE
Hubert Metzner · Marburg, DE
Christina Bodenbender · Lohra, DE

Key dates

Filing date	Jul 24, 2015
Grant date	Mar 26, 2019
Priority date	—
Expiry date	Jul 24, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P7/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to factor VIII compositions and their use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.